530 related articles for article (PubMed ID: 12957508)
1. APOE epsilon 3/ epsilon 4 heterozygotes have an elevated proportion of apolipoprotein E4 in cerebrospinal fluid relative to plasma, independent of Alzheimer's disease diagnosis.
Fukumoto H; Ingelsson M; Gårevik N; Wahlund LO; Nukina N; Yaguchi Y; Shibata M; Hyman BT; Rebeck GW; Irizarry MC
Exp Neurol; 2003 Sep; 183(1):249-53. PubMed ID: 12957508
[TBL] [Abstract][Full Text] [Related]
2. Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer's disease patients and controls.
Martínez-Morillo E; Hansson O; Atagi Y; Bu G; Minthon L; Diamandis EP; Nielsen HM
Acta Neuropathol; 2014 May; 127(5):633-43. PubMed ID: 24633805
[TBL] [Abstract][Full Text] [Related]
3. Plasma ApoE4 Levels Are Lower than ApoE2 and ApoE3 Levels, and Not Associated with Plasma Aβ40/42 Ratio as a Biomarker of Amyloid-β Amyloidosis in Alzheimer's Disease.
Nakamura T; Kawarabayashi T; Ueda T; Shimomura S; Hoshino M; Itoh K; Ihara K; Nakaji S; Takatama M; Ikeda Y; Shoji M
J Alzheimers Dis; 2023; 93(1):333-348. PubMed ID: 36970894
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein E (apoE) polymorphism and its influence on ApoE concentrations in the cerebrospinal fluid in Finnish patients with Alzheimer's disease.
Lehtimäki T; Pirttilä T; Mehta PD; Wisniewski HM; Frey H; Nikkari T
Hum Genet; 1995 Jan; 95(1):39-42. PubMed ID: 7814023
[TBL] [Abstract][Full Text] [Related]
5. In Thai Nationals, the ApoE4 Allele Affects Multiple Domains of Neuropsychological, Biobehavioral, and Social Functioning Thereby Contributing to Alzheimer's Disorder, while the ApoE3 Allele Protects Against Neuropsychiatric Symptoms and Psychosocial Deficits.
Tangwongchai S; Supasitthumrong T; Hemrunroj S; Tunvirachaisakul C; Chuchuen P; Houngngam N; Snabboon T; Tawankanjanachot I; Likitchareon Y; Phanthumchindad K; Maes M
Mol Neurobiol; 2018 Aug; 55(8):6449-6462. PubMed ID: 29307083
[TBL] [Abstract][Full Text] [Related]
6. The impact of apolipoprotein E4 on cause of death in Alzheimer's disease.
Olichney JM; Sabbagh MN; Hofstetter CR; Galasko D; Grundman M; Katzman R; Thal LJ
Neurology; 1997 Jul; 49(1):76-81. PubMed ID: 9222173
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein E in cerebrospinal fluid from patients with Alzheimer's disease and other forms of dementia is reduced but without any correlation to the apoE4 isoform.
Landén M; Hesse C; Fredman P; Regland B; Wallin A; Blennow K
Dementia; 1996; 7(5):273-8. PubMed ID: 8872419
[TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein E epsilon 4 allele in association with global cognitive performance and CSF markers in Alzheimer's disease.
Lasser RA; Dukoff R; Levy J; Levin R; Lehtimäki T; Seubert P; Sunderland T
Int J Geriatr Psychiatry; 1998 Nov; 13(11):767-74. PubMed ID: 9850873
[TBL] [Abstract][Full Text] [Related]
9. Reduced levels of cholesterol, phospholipids, and fatty acids in cerebrospinal fluid of Alzheimer disease patients are not related to apolipoprotein E4.
Mulder M; Ravid R; Swaab DF; de Kloet ER; Haasdijk ED; Julk J; van der Boom JJ; Havekes LM
Alzheimer Dis Assoc Disord; 1998 Sep; 12(3):198-203. PubMed ID: 9772023
[TBL] [Abstract][Full Text] [Related]
10. Influence of the susceptibility genes apolipoprotein E-epsilon 4 and apolipoprotein E-epsilon 2 on the rate of disease expressivity of late-onset Alzheimer's disease.
Roses AD; Saunders AM; Corder EH; Pericak-Vance MA; Han SH; Einstein G; Hulette C; Schmechel DE; Holsti M; Huang D
Arzneimittelforschung; 1995 Mar; 45(3A):413-7. PubMed ID: 7763336
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein E isoform-specific regulation of dendritic spine morphology in apolipoprotein E transgenic mice and Alzheimer's disease patients.
Ji Y; Gong Y; Gan W; Beach T; Holtzman DM; Wisniewski T
Neuroscience; 2003; 122(2):305-15. PubMed ID: 14614898
[TBL] [Abstract][Full Text] [Related]
12. Human Central Nervous System (CNS) ApoE Isoforms Are Increased by Age, Differentially Altered by Amyloidosis, and Relative Amounts Reversed in the CNS Compared with Plasma.
Baker-Nigh AT; Mawuenyega KG; Bollinger JG; Ovod V; Kasten T; Franklin EE; Liao F; Jiang H; Holtzman D; Cairns NJ; Morris JC; Bateman RJ
J Biol Chem; 2016 Dec; 291(53):27204-27218. PubMed ID: 27793990
[TBL] [Abstract][Full Text] [Related]
13. Central and Peripheral Mechanisms in ApoE4-Driven Diabetic Pathology.
Koren-Iton A; Salomon-Zimri S; Smolar A; Shavit-Stein E; Dori A; Chapman J; Michaelson DM
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32075060
[TBL] [Abstract][Full Text] [Related]
14. Expression of human apolipoprotein E3 or E4 in the brains of Apoe-/- mice: isoform-specific effects on neurodegeneration.
Buttini M; Orth M; Bellosta S; Akeefe H; Pitas RE; Wyss-Coray T; Mucke L; Mahley RW
J Neurosci; 1999 Jun; 19(12):4867-80. PubMed ID: 10366621
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the binding of amyloid-beta peptide to cell culture-derived native apolipoprotein E2, E3, and E4 isoforms and to isoforms from human plasma.
Yang DS; Smith JD; Zhou Z; Gandy SE; Martins RN
J Neurochem; 1997 Feb; 68(2):721-5. PubMed ID: 9003062
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease.
Poirier J; Delisle MC; Quirion R; Aubert I; Farlow M; Lahiri D; Hui S; Bertrand P; Nalbantoglu J; Gilfix BM; Gauthier S
Proc Natl Acad Sci U S A; 1995 Dec; 92(26):12260-4. PubMed ID: 8618881
[TBL] [Abstract][Full Text] [Related]
17. APOE and the regulation of microglial nitric oxide production: a link between genetic risk and oxidative stress.
Colton CA; Brown CM; Cook D; Needham LK; Xu Q; Czapiga M; Saunders AM; Schmechel DE; Rasheed K; Vitek MP
Neurobiol Aging; 2002; 23(5):777-85. PubMed ID: 12392781
[TBL] [Abstract][Full Text] [Related]
18. Human apoE3 but not apoE4 rescues impaired astrocyte activation in apoE null mice.
Ophir G; Meilin S; Efrati M; Chapman J; Karussis D; Roses A; Michaelson DM
Neurobiol Dis; 2003 Feb; 12(1):56-64. PubMed ID: 12609489
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
[TBL] [Abstract][Full Text] [Related]
20. Epidemiological, clinical, and neuropathological study of apolipoprotein E genotype in Alzheimer's disease.
Hyman BT; Gomez-Isla T; Rebeck GW; Briggs M; Chung H; West HL; Greenberg S; Mui S; Nichols S; Wallace R; Growdon JH
Ann N Y Acad Sci; 1996 Dec; 802():1-5. PubMed ID: 8993478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
